www.fdanews.com/articles/113721-clarient-launches-gene-expression-test-for-prostate-cancer
Clarient Launches Gene Expression Test for Prostate Cancer
January 13, 2009
Clarient, Inc., a premier anatomic pathology and molecular testing services resource for pathologists, oncologists, and the pharmaceutical industry, announced the commercial launch of its new gene expression test for prostate cancer.
Yahoo! Finance
Yahoo! Finance